Notice2024-16211

Deron Kovac, DMD; Decision and Order

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
July 24, 2024

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 142 (Wednesday, July 24, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 142 (Wednesday, July 24, 2024)]
[Notices]
[Pages 59930-59932]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16211]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Deron Kovac, DMD; Decision and Order

    On March 24, 2023, the Drug Enforcement Administration (DEA or 
Government) issued an Order to Show Cause (OSC) to Deron Kovac, D.M.D. 
(Registrant). Request for Final Agency Action (RFAA), Exhibit (RFAAX) 
1, at 1, 3. The OSC proposed the revocation of Registrant's 
Certification of Registration

[[Page 59931]]

No. FK7629340 at the registered address of 10493 Frankstown Road, Penn 
Hills, PA 15235. Id. at 1. The OSC alleged that Registrant's 
registration should be revoked because Registrant is ``currently 
without authority to prescribe, administer, dispense, or otherwise 
handle controlled substances in the Commonwealth of Pennsylvania, the 
state in which [he is] registered with DEA.'' Id. at 1-2 (citing 21 
U.S.C. 824(a)(3)).
    The OSC notified Registrant of his right to file with DEA a written 
request for hearing, and that if he failed to file such a request, he 
would be deemed to have waived his right to a hearing and be in 
default. Id. at 2 (citing 21 CFR 1301.43). Here, Registrant did not 
request a hearing. RFAA, at 2.\1\ ``A default, unless excused, shall be 
deemed to constitute a waiver of the registrant's/applicant's right to 
a hearing and an admission of the factual allegations of the [OSC].'' 
21 CFR 1301.43(e).
---------------------------------------------------------------------------

    \1\ Based on the Government's submissions in its RFAA dated 
October 12, 2023, the Agency finds that service of the OSC on the 
Registrant was adequate. Specifically, the submitted Declaration 
from a DEA Diversion Investigator indicates that Registrant was 
successfully mailed a copy of the OSC at both his last known address 
and his father's address on March 30, 2023, and April 25, 2023, 
respectively. RFAAX 2, at 1; see also id. at 3-10.
---------------------------------------------------------------------------

    Further, ``[i]n the event that a registrant . . . is deemed to be 
in default . . . DEA may then file a request for final agency action 
with the Administrator, along with a record to support its request. In 
such circumstances, the Administrator may enter a default final order 
pursuant to [21 CFR] Sec.  1316.67.'' Id. Sec.  1301.43(f)(1). Here, 
the Government has requested final agency action based on Registrant's 
default pursuant to 21 CFR 1301.43(c), (f), 1301.46. RFAA, at 1; see 
also 21 CFR 1316.67.

Findings of Fact

    The Agency finds that, in light of Registrant's default, the 
factual allegations in the OSC are admitted. According to the OSC, 
effective October 18, 2022, the Pennsylvania State Board of Dentistry 
suspended Registrant's dental license. RFAAX 1, at 1. According to 
Pennsylvania online records, of which the Agency takes official notice, 
Registrant's dental license remains suspended.\2\ Pennsylvania 
Licensing System Verification Service, <a href="https://www.pals.pa.gov/#!/page/search">https://www.pals.pa.gov/#!/page/search</a> (last visited date of signature of this Order). Accordingly, the 
Agency finds that Registrant is not licensed to practice dentistry in 
Pennsylvania, the state in which he is registered with DEA.
---------------------------------------------------------------------------

    \2\ Under the Administrative Procedure Act, an agency ``may take 
official notice of facts at any stage in a proceeding--even in the 
final decision.'' United States Department of Justice, Attorney 
General's Manual on the Administrative Procedure Act 80 (1947) (Wm. 
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e), 
``[w]hen an agency decision rests on official notice of a material 
fact not appearing in the evidence in the record, a party is 
entitled, on timely request, to an opportunity to show the 
contrary.'' Accordingly, Registrant may dispute the Agency's finding 
by filing a properly supported motion for reconsideration of 
findings of fact within fifteen calendar days of the date of this 
Order. Any such motion and response shall be filed and served by 
email to the other party and to the DEA Office of the Administrator, 
Drug Enforcement Administration at <a href="/cdn-cgi/l/email-protection#cda9a8ace3aca9a9a2e3acb9b9a2bfa3a8b4be8da9a8ace3aaa2bb"><span class="__cf_email__" data-cfemail="e1858480cf8085858ecf8095958e938f849892a1858480cf868e97">[email&#160;protected]</span></a>.
---------------------------------------------------------------------------

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under 21 U.S.C. 823 ``upon a 
finding that the registrant . . . has had his State license or 
registration suspended . . . [or] revoked . . . by competent State 
authority and is no longer authorized by State law to engage in the . . 
. dispensing of controlled substances.'' With respect to a 
practitioner, DEA has also long held that the possession of authority 
to dispense controlled substances under the laws of the state in which 
a practitioner engages in professional practice is a fundamental 
condition for obtaining and maintaining a practitioner's registration. 
See, e.g., James L. Hooper, D.O., 76 FR 71371, 71372 (2011), pet. for 
rev. denied, 481 F. App'x 826 (4th Cir. 2012); Frederick Marsh Blanton, 
D.O., 43 FR 27616, 27617 (1978).\3\
---------------------------------------------------------------------------

    \3\ This rule derives from the text of two provisions of the 
Controlled Substances Act (CSA). First, Congress defined the term 
``practitioner'' to mean ``a physician . . . or other person 
licensed, registered, or otherwise permitted, by . . . the 
jurisdiction in which he practices . . . , to distribute, dispense, 
. . . [or] administer . . . a controlled substance in the course of 
professional practice.'' 21 U.S.C. 802(21). Second, in setting the 
requirements for obtaining a practitioner's registration, Congress 
directed that ``[t]he Attorney General shall register practitioners 
. . . if the applicant is authorized to dispense . . . controlled 
substances under the laws of the State in which he practices.'' 21 
U.S.C. 823(g)(1). Because Congress has clearly mandated that a 
practitioner possess state authority in order to be deemed a 
practitioner under the CSA, DEA has held repeatedly that revocation 
of a practitioner's registration is the appropriate sanction 
whenever he is no longer authorized to dispense controlled 
substances under the laws of the state in which he practices. See, 
e.g., James L. Hooper, 76 FR 71371-72; Sheran Arden Yeates, D.O., 71 
FR 39130, 39131 (2006); Dominick A. Ricci, D.O., 58 FR 51104, 51105 
(1993); Bobby Watts, D.O., 53 FR 11919, 11920 (1988); Frederick 
Marsh Blanton, 43 FR 27617.
---------------------------------------------------------------------------

    According to Pennsylvania statute, ``dispense'' means ``to deliver 
a controlled substance, other drug or device to an ultimate user or 
research subject by or pursuant to the lawful order of a practitioner, 
including the prescribing, administering, packaging, labeling, or 
compounding necessary to prepare such item for that delivery.'' 35 Pa. 
Stat. and Cons. Stat. Ann. section 780-102(b) (West 2024). Further, a 
``practitioner'' means ``a physician . . . dentist . . . or other 
person licensed, registered or otherwise permitted to distribute, 
dispense, conduct research with respect to or to administer a 
controlled substance, other drug or device in the course of 
professional practice or research in the Commonwealth of 
Pennsylvania.'' Id.
    Here, the undisputed evidence in the record is that Registrant 
lacks authority to practice dentistry in Pennsylvania. As discussed 
above, an individual must be a licensed practitioner to dispense a 
controlled substance in Pennsylvania. Thus, because Registrant lacks 
authority to practice dentistry in Pennsylvania and, therefore, is not 
authorized to handle controlled substances in Pennsylvania, Registrant 
is not eligible to maintain a DEA registration. Accordingly, the Agency 
will order that Registrant's DEA registration be revoked.

Order

    Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. 
FK7629340 issued to Deron Kovac, D.M.D. Further, pursuant to 28 CFR 
0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I 
hereby deny any pending applications of Deron Kovac, D.M.D., to renew 
or modify this registration, as well as any other pending application 
of Deron Kovac, D.M.D., for additional registration in Pennsylvania. 
This Order is effective August 23, 2024.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
July 15, 2024, by Administrator Anne Milgram. That document with the 
original signature and date is maintained by DEA. For administrative 
purposes only, and in compliance with requirements of the Office of the 
Federal Register, the undersigned DEA Federal Register Liaison Officer 
has been authorized to sign and submit the document in electronic 
format for publication, as an official document of DEA. This 
administrative process in no way alters the legal effect of this

[[Page 59932]]

document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2024-16211 Filed 7-23-24; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on July 24, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.